All companies › TXG

TXG · 10x Genomics, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells10
Research cases0
Last filing2026-09-22

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-22 — Saxonov Serge · sold 1,000 @ $78.23 2026-09-22 — Saxonov Serge · sold 2,000 @ $79.62 2026-09-22 — Saxonov Serge · sold 2,800 @ $82.37 2026-09-22 — Saxonov Serge · sold 9,300 @ $80.90 2026-09-22 — Saxonov Serge · sold 9,900 @ $81.83 2026-09-22 — SULIMAN SHEHNAAZ · sold 1,222 @ $82.28 2026-09-22 — SULIMAN SHEHNAAZ · sold 1,325 @ $80.82 2026-09-22 — SULIMAN SHEHNAAZ · sold 2,270 @ $81.67 2026-09-22 — SULIMAN SHEHNAAZ · sold 292 @ $78.20 2026-09-22 — SULIMAN SHEHNAAZ · sold 614 @ $79.51
2026-09-222026-09-22

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Saxonov Serge Chief Executive Officer, Director
SULIMAN SHEHNAAZ Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $TXG is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-22', 'insider_name': 'Saxonov Serge', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 1000.0, 'price': 78.23, 'value': 78230.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Saxonov Serge', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 2000.0, 'price': 79.62, 'value': 159240.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Saxonov Serge', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 2800.0, 'price': 82.37, 'value': 230636.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Saxonov Serge', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 9300.0, 'price': 80.9, 'value': 752370.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'Saxonov Serge', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 9900.0, 'price': 81.83, 'value': 810117.0, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'SULIMAN SHEHNAAZ', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1222.0, 'price': 82.28, 'value': 100546.16, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'SULIMAN SHEHNAAZ', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1325.0, 'price': 80.82, 'value': 107086.5, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'SULIMAN SHEHNAAZ', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 2270.0, 'price': 81.67, 'value': 185390.9, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'SULIMAN SHEHNAAZ', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 292.0, 'price': 78.2, 'value': 22834.4, 'is_buy': False}, {'transaction_date': '2026-09-22', 'insider_name': 'SULIMAN SHEHNAAZ', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 614.0, 'price': 79.51, 'value': 48819.14, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for TXG today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.